AZ CEO Pascal Soriot recorded an interview with PharmaDispatch during his recent trip to Australia.
In the first of a two-part interview, he discusses the new AstraZeneca, his personal affinity with 'home' in Australia and how it 'breaks his heart' governments here have not done more to grow innovative industries.
AZ's Pascal Soriot: 'My Australia and the new AstraZeneca'
January 31, 2019 BioPharmaDispatch ExecutiveNews of the Day
Latest Video
Georgia Forrest
New Stories
-
Australian medtech secures funds to advance real-time breast cancer surgery technology
February 13, 2026 - - Australian Biotech -
The Dispatched Podcast 'Week in Review' - 13 February
February 13, 2026 - - Podcast -
PBAC to reconsider broader vaccine funding after late addition to March agenda
February 13, 2026 - - Latest News -
Ten years of process 'improvements' is almost the point, says Anne Ruston
February 13, 2026 - - Latest News -
Senate scrutiny of PBS rules after Canberra family highlights lack of biologic access
February 12, 2026 - - Latest News -
There is no negotiation, yet, so be careful not to give the impression of conceding anything
February 11, 2026 - - Latest News -
Arrotex and Pfizer forge strategic pharmacy partnership for ENBREL in Australia
February 11, 2026 - - Latest News